Early Check-In Protocol: Identifying Medication Issues in Patients with Cancer at Health System Specialty Pharmacy
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900251318574 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Kayla Ann Phillips und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mercer University College of Pharmacy, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Pharmacists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
Several studies have illustrated value in early patient contact following oral anticancer medication (OAM) initiation, particularly within the first 14 days of therapy, as adverse effects may lead to early discontinuation or poor adherence. Health-system specialty pharmacies (HSSPs) are optimally positioned to adopt this best practice through formalized protocols designed to identify and mitigate medication-related issues.
Objective
To outline an HSSP-led early check-in protocol for patients taking OAMs and to describe the subsequent interventions conducted by the HSSP team and their acceptance rate.
Results
HSSPs enacted a protocol in January 2021 requiring oncology pharmacists - to contact patients within 14 days of OAM initiation, aiming to optimize adverse effect management, offer supportive care, address adherence, and provide education. To evaluate the impact of the early check-in protocol, we conducted a retrospective, multicenter, observational study across CPS’s health system clients from January 2022 to November 2023. HSSP pharmacists created 1698 interventions for 1184 patients from the early check-in. The cancer types most frequently associated with an intervention were breast (n = 431, 25.4%), gastrointestinal (n = 245, 14.4%), and prostate (n = 206, 12.1%). The most frequent intervention categories were adverse drug reactions (ADRs) (n = 1,548, 91.2%) and adherence (n = 55, 3.2%). Overall, 95.5% of pharmacist recommendations were accepted by patients and/or providers.
Conclusion
Implementing an early check-in protocol allows HSSP pharmacists to mitigate barriers to OAM adherence. This study emphasizes the importance of early check-in and illustrates the scope of the oncology pharmacist’s role by evaluating critically meaningful interventions and quantifying pharmacist recommendations and acceptance rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mercer University College of Pharmacy, Atlanta, GA, USA.
- Outpatient Specialty, CPS Solutions, LLC (CPS), Dublin, OH, USA.
ORCID-Profile: Kayla Ann Phillips, Ana I Lopez-Medina
Zitieren
APA
Phillips, K. A., Wash, A., Hutchinson, K., Cash, K. J., Giavatto, C., Fitzpatrick, C., Hunter, A., Page, O., Mourani, J., & Lopez-Medina, A. I. (2025). Early Check-In Protocol: Identifying Medication Issues in Patients with Cancer at Health System Specialty Pharmacy. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251318574
Vancouver
Phillips KA, Wash A, Hutchinson K, Cash KJ, Giavatto C, Fitzpatrick C, et al. Early Check-In Protocol: Identifying Medication Issues in Patients with Cancer at Health System Specialty Pharmacy. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900251318574
BibTeX
@article{Phillips2025,
author = {Phillips, Kayla Ann and Wash, Andrew and Hutchinson, Kristin and Cash, Katie Jo and Giavatto, Carly and Fitzpatrick, Casey and Hunter, Abbey and Page, Olivia and Mourani, Jessica and Lopez-Medina, Ana I},
title = {Early Check-In Protocol: Identifying Medication Issues in Patients with Cancer at Health System Specialty Pharmacy},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900251318574}
}
EUVIMED